Maria Jacquez
Family · El Paso, TXNPI 1518290964
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 545 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,768 and has fallen 54.0% since, to $1,273 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 545 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$917
- Bayer$852
- Novo Nordisk$676
- AstraZeneca$546
- Dexcom, Inc.$536
- Amgen$499
- plus $5K from 37 others
What the payments were for
- Food & beverage$8,661100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$124
- STELARA$110
How this compares
$8,661 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 97 | $111,010 |
| FarxigaDapagliflozin Propanediol | 58 | $65,055 |
| EliquisApixaban | 61 | $54,150 |
| OzempicSemaglutide | 42 | $48,354 |
| RybelsusSemaglutide | 23 | $39,549 |
| JanuviaSitagliptin Phosphate | 31 | $33,022 |
| JardianceEmpagliflozin | 23 | $28,758 |
| VascepaIcosapent Ethyl | 32 | $19,806 |
| MyrbetriqMirabegron | 20 | $19,258 |
| TrulicityDulaglutide | 13 | $17,381 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $14,030 |
| CreonLipase/Protease/Amylase | 14 | $10,814 |
| Repatha SureclickEvolocumab | 13 | $8,201 |
| XareltoRivaroxaban | 11 | $8,169 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $7,559 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $917 | $128,391110 claims |
| Novo NordiskOzempic, Rybelsus | $676 | $87,90365 claims |
| AstraZenecaFarxiga | $546 | $65,05558 claims |
| PfizerEliquis, Paxlovid | $348 | $55,50999 claims |
| MerckJanuvia | $70 | $33,02231 claims |
| Boehringer IngelheimJardiance | $355 | $28,75823 claims |
| Astellas Pharma US IncMyrbetriq | $161 | $19,25820 claims |
| AbbVieCreon, Synthroid | $475 | $14,22151 claims |
| Johnson & JohnsonXarelto | $290 | $8,16911 claims |
| GSKTrelegy Ellipta | $497 | $6,96411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in El Paso
- Margarita FavelaEl Paso$73K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.